高密度多孔聚乙烯植入体在鼻整形中的应用

目的 探究高密度多孔聚乙烯植入体在鼻整形中的应用价值方法 选取2019年5月-2021年8月我院接受综合鼻整形手术的106例患者为研究对象，采用照随机数字表法分为对照组和观察组，各53例。 对照组采用自体肋骨植入术，观察组采用高密度多孔聚乙烯植入体植入治疗，比较两组临床手术指标(手术时间、恢复时间)、整形优良率、鼻指标(鼻高度/鼻长度比例、鼻唇角)、并发症发生率以及疼痛评分结果 观察组手术时间、术后恢复时间均短于对照组(P＜0.05)；观察组整形优良率为94.34%，高于对照组的86.79%，差异有统计学意义(P＜0.05)；观察组鼻高度/鼻长度比例高于对照组，鼻唇角小于对照组，差异有统计学意义(P＜0.05)；观察组并发症发生率为5.66%，低于对照组的15.09%，差异有统计学意义(P＜0.05)；观察组疼痛评分低于对照组，差异有统计学意义(P＜0.05)；观察组治疗满意度为 96.23%，高于对照组的84.91%，差异有统计学意义(P＜0.05)结论 高密度多孔聚乙烯植入体在鼻整形中的应用效果理想，可减轻患者疼痛度，缩短手术和恢复时间，降低并发症发生率，改善鼻高度/鼻长度比例和鼻唇角，实现理想的整形效果。     

蒙药朱日亨滴丸源头把控——基于Q-Exactive高分辨质谱结合指纹图谱技术的蒙药广枣药材质量评价研究

目的 运用Q-Exactive高分辨质谱结合指纹图谱评价不同批次广枣药材质量,为朱日亨滴丸源头把控提供参考。方法 采用Agilent ZORBAX ECLIPSE XDB-C18色谱柱,以0.1%甲酸水-甲醇梯度洗脱30min,柱温为30℃,流速为1.0ml.min^-1。采用电喷雾(ESI)质谱离子源,在正离子与负离子模式下采集数据,检测范围为m/z 100-1500。依据精确质量数以及二级碎片离子,结合标准物质及相关数据库信息,对蒙药广枣药材主要化学成分进行定性研究。同时测定10批广枣药材,应用“中药色谱指纹图谱相似度评价系统(2004A)”建立广枣指纹图谱,并对各共有峰进行化学成分归属,对鞣花酸进行定量,评价各批次药材的质量。结果 鉴定出广枣中的37种化合物,并以鞣花酸为参照物,建立广枣药材指纹图谱,10批次广枣药材相似均在0.90以上。不同批次广枣药材鞣花酸含量差异明显。结论 建立基于Q-Exactive高分辨质谱结合指纹图谱技术的蒙药广枣药材质量评价研究方法为广枣药材质量控制提供参考,也为主日亨滴丸源头保证提供科学依据。     

阴茎异常勃起14例临床分析

目的:探讨阴茎异常勃起的诊断、治疗及预后。方法:回顾性分析阴茎异常勃起患者14例的临床资料,其中血管活性药物所致8例,白血病所致2例,会阴外伤所致1例,原因不明3例。给予海绵体血气分析、阴茎彩色多普勒超声等检查,作海绵体穿刺减压及分流手术等治疗。结果:13例为低流量型异常勃起,1例为高流量型异常勃起,治疗后异常勃起均缓解。随访3~46个月,4例发生不同程度的海绵体纤维化或勃起功能障碍。结论:海绵体血气分析和彩色多普勒超声等检查有助于阴茎异常勃起准确及时的诊断。对于低流量型异常勃起,早期及时正确的治疗是避免术后海绵体纤维化、勃起功能障碍发生的关键。     

膀胱移行细胞癌Mta-1基因与蛋白表达及其临床意义

目的:检测膀胱移行细胞癌(BTCC)中Mta-1mRNA与蛋白表达,分析其与BTCC临床分期、病理分级、转移及复发的关系。方法:原位杂交、免疫组化方法检测42例BTCC组织Mta-1mRNA与蛋白的表达;CD34标记血管内皮细胞,计数肿瘤组织微血管密度(MVD);结合临床病理资料,分析Mta-1与BTCC的侵袭转移、血管生成及复发间的关系。结果:①Mta-1mRNA与蛋白在BTCC中高度表达,其表达阳性率分别为78.6%、73.8%,与正常组织比较差异有统计学意义(P<0.01),且随BTCC临床分期及病理分级的升高而增加,肿瘤复发组高于无复发组,肿瘤转移组高于无转移组(P<0.05)。②经非参数相关分析发现,Mta-1蛋白与Mta-1mR-NA表达呈高度正相关,Rs为0.945,P=0.000;CD34标染的微血管密度(MVD)与Mta-1mRNA与蛋白表达亦呈正相关,相关系数分别为0.712、0.683,P=0.000。结论:①Mta-1在膀胱移行细胞癌中高度表达,并随着肿瘤临床分期和病理分级的升高而增加,与肿瘤的转移及复发密切相关。②Mta-1参与膀胱移行细胞癌的侵袭、转移,可能与促进血管生成有关。     

Inhibition of human benzylamine oxidase (BzAO) by analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

A sensitive assay for human plasma BzAO, involving the conversion of 14C-benzylamine to 14C-benzaldehyde, was developed. MPTP and several of its analogues were found to be competitive inhibitors of the enzyme. Ki values for the MPTP analogues in the presence of human plasma BzAO were determined. The analogues had a different rank order of inhibition of human plasma BzAO compared with the rank order of inhibition of bovine plasma BzAO found previously. MPTP and 1-methyl-4-(2-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP), which are potent nigrostriatal toxins, were weak inhibitors of human plasma BzAO.     

胫腓骨下段开放性粉碎骨折的治疗(附20例临床报告)

目的探讨胫腓骨下段开放性粉碎骨折的综合治疗。方法20例胫腓骨下段开放性粉碎骨折采用半环槽式外固定器固定、皮瓣转移、腓骨内移、骨折端加压并同期行上干骺端骨延长等综合治疗方法。结果伤口均一期愈合，所有皮瓣均成活，骨折临床愈合平均时间19周，7例因严重骨缺损经骨折端加压并同期行上干骺端骨延长后肢体均恢复正常长度。无1例针眼感染和血管、神经损伤。临床优良率为90％(18／20)。结论a)半环槽外固定器能克服胫腓骨下段开放性粉碎骨折的治疗困难，具有立体均衡固定。刚性可调，避免肢体受压。便于再次创面处理以及同期行骨折端加压和肢体延长等优点。b)半环槽式外固定器结合皮瓣转移、腓骨内移以及骨折端加压并同期行上干骺端骨延长等综合治疗方法是胫腓骨下段开放性粉碎骨折可选择的较好治疗措施之一。     

重视膀胱癌淋巴管浸润和淋巴结转移的研究

转移是膀胱癌患者死亡的主要原因,且早期以淋巴结转移为主。T2 期膀胱癌约 50%淋巴管内有癌细胞,T3 期几乎全部淋巴管内有癌细胞。残存的肿瘤细胞淋巴管浸润是肿瘤切除术后复发的根源,明显的淋巴结转移更是患者预后不良的重要危险因素。然而膀胱癌淋巴管浸润和淋巴结转移的     

碘伏用于超声根管预备预防根管治疗期间痛的临床研究

目的观察碘伏用于超声根管预备对死髓牙根管治疗期间痛(endodontic interappointment pain EIP)发生率的影响及防治效果.方法对159例180颗慢性根尖周炎患者,随机分为3组(每组60颗患牙).第1组为传统手持器械对照组,第2组为超声生理盐水对照组,第3组为超声碘伏治疗组.采用临床观察分析法,观察治疗组与对照组临床反应的差异.结果超声治疗组Ⅱ～Ⅲ级EIP发生率为10%,对照组为36.67%(P＜0.01),有显著差异性.结论碘伏应用于超声根管预备能预防和降低EIP的发生并减轻其疼痛程度.     

Suppression of canine antral gastrin secretion by urine

Distention of the gastric antrum with an alkaline fluid normally results in the secretion of gastrin. Following gastrocystoplasty in humans, however, hypergastrinemia has not been observed. We explored the possibility that a component of urine may suppress antral gastrin activity in the dog. Partial cystectomy and antral transposition to the bladder (ATB) was performed in five animals and antral transposition to the colon (ATC) was performed in five other dogs to serve as a hypergastrinemic controls. At four and eight weeks after surgery the mean serum gastrin levels in the ATC dogs were significantly greater than the mean preoperative levels (p less than 0.05). In contrast, at four and eight weeks after surgery the mean serum gastrin levels in the ATB animals were significantly less than the mean preoperative levels (p less than 0.05). The antral G-cell density as determined by immunohistochemical study at eight weeks after surgery was greater than normal in the ATC dogs but less than normal in the ATB dogs; but the differences did not achieve statistical significance. In another series of experiments using four other dogs a 4% aqueous peptone solution and a 4% peptone solution in concentrated dog urine were instilled into exteriorized antral pouches. The mean serum gastrin levels at 60 and 90 minutes after instillation of the former were significantly increased (p less than 0.05), but there was little or no change after instillation of the latter. Urine, or a component of urine, appears to suppress canine antral gastrin secretion and may explain the absence of hypergastrinemia following gastrocystoplasty in humans.